Currency In USD
| Previous Close | 0.1 |
| Open | 0.1 |
| Day High | 0.1 |
| Day Low | 0.1 |
| 52-Week High | 1.5 |
| 52-Week Low | 0.09 |
| Volume | 0 |
| Average Volume | 15.8M |
| Market Cap | 14.86M |
| PE | -1.03 |
| EPS | -0.1 |
| Moving Average 50 Days | 0.15 |
| Moving Average 200 Days | 0.46 |
| Change | 0 |
Data not available
Applied Therapeutics Shares Letter to Stockholders Recommending Tender of Shares Following Offer Expiration Extension
GlobeNewswire Inc.
Jan 29, 2026 1:15 PM GMT
NEW YORK, Jan. 29, 2026 (GLOBE NEWSWIRE) -- Applied Therapeutics, Inc. (Nasdaq: APLT) (the “Company” or “Applied”), a clinical-stage biopharmaceutical company dedicated to creating transformative treatments for rare diseases, today released the fol
Cycle Pharmaceuticals to Acquire Applied Therapeutics
GlobeNewswire Inc.
Dec 11, 2025 10:25 PM GMT
Applied Therapeutic’s lead drug candidate, govorestat, is a novel central nervous system penetrant Aldose Reductase Inhibitor for the treatment of CNS rare metabolic diseasesNEW YORK, Dec. 11, 2025 (GLOBE NEWSWIRE) -- Applied Therapeutics, Inc. (Na
Applied Therapeutics Announces Corporate Updates
GlobeNewswire Inc.
Nov 20, 2025 12:00 PM GMT
NEW YORK, Nov. 20, 2025 (GLOBE NEWSWIRE) -- Applied Therapeutics, Inc. (Nasdaq: APLT) (the “Company”), a clinical-stage biopharmaceutical company dedicated to creating transformative treatments for rare diseases, today announced that Applied Therap